Bio Rad Laboratories Inc
NYSE:BIO
Net Margin
Bio Rad Laboratories Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | US |
Market Cap | 8.4B USD |
Net Margin |
-12%
|
Country | US |
Market Cap | 230B USD |
Net Margin |
14%
|
Country | US |
Market Cap | 192B USD |
Net Margin |
18%
|
Country | US |
Market Cap | 44.3B USD |
Net Margin |
18%
|
Country | US |
Market Cap | 42B USD |
Net Margin |
9%
|
Country | KR |
Market Cap | 55.6T KRW |
Net Margin |
23%
|
Country | CH |
Market Cap | 36.7B CHF |
Net Margin |
10%
|
Country | US |
Market Cap | 32B USD |
Net Margin |
21%
|
Country | IE |
Market Cap | 26.1B USD |
Net Margin |
8%
|
Country | US |
Market Cap | 25.9B USD |
Net Margin |
19%
|
Country | US |
Market Cap | 21.3B USD |
Net Margin |
21%
|
Profitability Report
View the profitability report to see the full profitability analysis for Bio Rad Laboratories Inc.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Bio Rad Laboratories Inc's most recent financial statements, the company has Net Margin of -12.4%.